Isabella Bertold

Relentless has an unwavering commitment to invest in the commercialization of disruptive technology, products, and services that optimize access to care and facilitate a robust continuum of care. We invest in leading-edge clinical research and technologies that manage health risk factors and treat chronic conditions. As technology and mission based investors, we are committed to the development of technologies, products and services that both enhance and promote an individual’s ability to stay optimally healthy and active over an entire lifetime. We target investment at the early stage of a business, the ‘start up’ phase. As early stage investors, we influence product and market development, while tapping into the experience of our seasoned advisors and unique North American network to create additional value. Opportunistically, we include development stage businesses for portfolio balance. Investment Sectors: Preventive health, chronic disease management, seniors'​ health, digital health, corporate wellness, personal nutrition, behaviour modification, mental wellbeing, neurotech, diabetes, cardiovascular disease, mobility, sensor technology, 3D-printing and healthy longevity.